drugset / Trial / NCT02632747

Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study

NCT02632747

RandomizedCrossoverDouble-blindTreatment

Summary

This is a randomized, double-blind, double-dummy, placebo-controlled, cross over design trial with empagliflozin compared to placebo that is added to open-label ramipril.

Timeline

Start
2016-05-10
Primary completion
2017-12-19
Completion
2019-07-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Empagliflozin Small molecule 25 mg
Background Ramipril Small molecule 10 mg